You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.
Latest Diabetes Articles
Popular Diabetes Articles
Highly Recommended Diabetes Articles
Send a link to this page to your friends and colleagues.
The Harvard findings are a boon to researchers because they confirm that adult cells are
By "reprogramming" adult exocrine cells in mice pancreases to function as beta-like insulin producers, Harvard biologists have taken a giant step toward the use of cell regeneration therapy in the treatment of type 1 diabetes.
Building on a technique developed by Japanese biologist Shinya Yamanaka, Harvard researchers led by Qiao Zhou and Douglas A. Melton were able to return adult cells to an embryonic state in which they could be coaxed to take on a different function.
Yamanaka's technique involved inserting proteins called transcription factors into the adult cells. Transcription factors control which genes are active in a cell and, therefore, its function.
The Harvard team identified three transcription factors that are active in the insulin-producing cells of the pancreas. They "hitched" the genes for these three factors to a virus that is known to infect exocrine cells in the pancreas.
Exocrine cells infected by the virus began taking on beta cell-like functions, including the production of insulin. The altered cells, however, did not cluster together in islets the way that genuine original beta cells do.
The Implications
The Harvard findings are a boon to researchers because they confirm that adult cells are "pliable" enough to be manipulated to a degree greater than previously thought possible. Research with embryonic cells has taken longer than expected to produce the same kinds of results scientists are now enjoying with adult cells.
However, there are some cautions involved. For one thing, the FDA currently forbids the injection of viruses into human subjects for research. For another, although laboratory mice are analogous to human beings in many ways, there will have to be more research into whether human exocrine cells can be altered as readily as those in mice.
Categories: Diabetes, Diabetes, Insulin, Other Lab Tests, Type 1 Issues
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.

Comments
Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.
When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.
For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.
Don't have your Diabetes Health Username? Register now and add your comments to all our content.
Register...
Register your Diabetes Health Username here.
Have Your Say...